BRIEF-EMA Starts Evaluating Use Of Comirnaty In Children Aged 6 Months To 4 Years

BRIEF-EMA Starts Evaluating Use Of Comirnaty In Children Aged 6 Months To 4 Years

European Medicines Agency: * EMA - EMA STARTED EVALUATING THE USE OF COMIRNATY IN CHILDREN AGED 6 MONTHS TO 4 YEARS

* EMA - STARTED EVALUATING RENEWAL OF CONDITIONAL MARKETING AUTHORISATION FOR NUVAXOVID * EMA - STARTED EVALUATING RENEWAL OF CONDITIONAL MARKETING AUTHORISATION FOR SPIKEVAX Further company coverage:

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.